Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?

Norbert Pardi of the Perelman School of Medicine comments on how mRNA is so quick and easy to produce, that vaccines can be designed to strike many sites simultaneously. 

・ From The Guardian